(19)
(11) EP 1 778 724 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.01.2011 Bulletin 2011/04

(45) Mention of the grant of the patent:
15.12.2010 Bulletin 2010/50

(21) Application number: 05774139.9

(22) Date of filing: 11.08.2005
(51) International Patent Classification (IPC): 
C07K 14/61(2006.01)
C07K 14/78(2006.01)
C07K 14/155(2006.01)
A61K 38/39(2006.01)
A61P 43/00(2006.01)
 C07K 14/575(2006.01)
C07K 14/47(2006.01)
A61K 38/22(2006.01)
A61K 38/16(2006.01)
(86) International application number:
PCT/EP2005/053952
(87) International publication number:
WO 2006/018418 (23.02.2006 Gazette 2006/08)

(54)

ANTIANGIOGENIC PEPTIDES

ANTIANGIOGENE PEPTIDE

PEPTIDES ANTI-ANGIOGENIQUES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 16.08.2004 EP 04103920

(43) Date of publication of application:
02.05.2007 Bulletin 2007/18

(73) Proprietor: Université de Liège
4031 Angleur (BE)

(72) Inventors:
  • MARTIAL, Joseph
    B-4577 Modave (BE)
  • STRUMAN, Ingrid
    B-4100 Boncelles (BE)
  • NGUYEN, Ngoc-Quynh-Nhu
    B-4000 Liège (BE)
  • BRASSEUR, Robert
    B-5351 Haillot (BE)
  • LINS, Laurence
    B-1450 Chastre (BE)

(74) Representative: Polypatent 
Postfach 40 02 43
51410 Bergisch Gladbach
51410 Bergisch Gladbach (DE)


(56) References cited: : 
EP-A- 1 378 515
 WO-A-98/51323
   
  • BUSHELL G ET AL: "EVIDENCE SUPPORTING A ROLE FOR CATHEPSIN B IN THE GENERATION OF T CELL ANTIGENIC EPITOPES OF HUMAN GROWTH HORMONE" MOLECULAR IMMUNOLOGY, ELMSFORD, NY, US, vol. 30, no. 6, 1 April 1993 (1993-04-01), pages 587-591, XP000576440 ISSN: 0161-5890
  • PIOSSEK C ET AL: "VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTOR II-DERIVED PEPTIDES INHIBIT VEGF" JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 274, no. 9, 26 February 1999 (1999-02-26), pages 5612-5619, XP000999231 ISSN: 0021-9258
  • LINS L ET AL: "Computational study of lipid-destabilizing protein fragments: towards a comprehensive view of tilted peptides." PROTEINS. 1 SEP 2001, vol. 44, no. 4, 1 September 2001 (2001-09-01), pages 435-447, XP002313645 ISSN: 0887-3585
  • DINGS RUUD P M ET AL: "Discovery and development of anti-angiogenic peptides: A structural link." ANGIOGENESIS. 2003, vol. 6, no. 2, 2003, pages 83-91, XP002313646 ISSN: 0969-6970
  • J.BIOL.CHEM., vol. 271, no. 24, 14 June 1996 (1996-06-14), pages 14353-14360,
  • J.NEUROIMMUNOL., vol. 109, 2000, pages 56-62,
  • J.ENDOCRINOL., vol. 173, 2002, pages 219-238,
  • BALDOCCHI E.A.: ENDOCRINOLOGY, vol. 133, no. 2, 1993, pages 935-938,
  • FERRARA E.A.: ENDOCRINOLOGY, vol. 129, no. 2, 1991, pages 896-900,
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).